Brain cancer research seems to place a great amount of focus on glioblastoma and it's not hard to see why. To many, it is the kind of condition that those in this particular field are able to focus on, seeing as how it is one of the more detrimental ones from a medical standpoint. That being said, is it possible that combination of drugs can come into great effect in the long term? I believe this to be especially true, as this ailment has impacted a number of patients.
US News and World Report posted an article about a potential treatment that could prove useful for the sake of treating glioblastoma. This is one point that should be looked into but you have to keep in mind that this condition stands as one of the most aggressive and common conditions seen in the brain. According to a study that was done by the University of Zurich, it is "virtually incurable." That being said, it seems like a two-pronged drug therapy approach could prove useful in the long term.
The study group at the university looked into this condition more so, utilizing mice in order to see how a drug combination could be utilized. The mice were given both a T cell-boosting protein - dubbed interleukin-12 - as well as a drug that would be able to block off the inhibitory function that is commonly associated with the T cell. Keep in mind that while only IL-12 could be put to use, it was determined that mice had a boosted survival rate of 25%. However, the results should not stop at this point, should they?
To me, this is one of the best cases that can be taken into account and I do not think that anyone in the realm of brain cancer research can overlook this. This is especially true when you take into consideration that the T cells, thanks to the incorporation of another drug, can be halted in terms of regulation. The way that this could prove beneficial is through the survival rate boosting from 25% to 80%. It's a great point to consider, which is especially true for organizations along the lines of V-A-B-C.
Even if this procedure does not prove to be helpful in the long term, it is clear that there are possibilities that exist. They have to be able to come about or else the level of brain cancer research seen is not going to be nearly as tremendous as it should be. The drug combination spoken about here has proven itself to be especially noteworthy, which is something that is hard to overlook. It is important to keep this in mind so that, in time, other strategies can come into effect.
US News and World Report posted an article about a potential treatment that could prove useful for the sake of treating glioblastoma. This is one point that should be looked into but you have to keep in mind that this condition stands as one of the most aggressive and common conditions seen in the brain. According to a study that was done by the University of Zurich, it is "virtually incurable." That being said, it seems like a two-pronged drug therapy approach could prove useful in the long term.
The study group at the university looked into this condition more so, utilizing mice in order to see how a drug combination could be utilized. The mice were given both a T cell-boosting protein - dubbed interleukin-12 - as well as a drug that would be able to block off the inhibitory function that is commonly associated with the T cell. Keep in mind that while only IL-12 could be put to use, it was determined that mice had a boosted survival rate of 25%. However, the results should not stop at this point, should they?
To me, this is one of the best cases that can be taken into account and I do not think that anyone in the realm of brain cancer research can overlook this. This is especially true when you take into consideration that the T cells, thanks to the incorporation of another drug, can be halted in terms of regulation. The way that this could prove beneficial is through the survival rate boosting from 25% to 80%. It's a great point to consider, which is especially true for organizations along the lines of V-A-B-C.
Even if this procedure does not prove to be helpful in the long term, it is clear that there are possibilities that exist. They have to be able to come about or else the level of brain cancer research seen is not going to be nearly as tremendous as it should be. The drug combination spoken about here has proven itself to be especially noteworthy, which is something that is hard to overlook. It is important to keep this in mind so that, in time, other strategies can come into effect.
About the Author:
Contact Voices Against Brain Cancer if you're looking for some more information about brain cancer awareness and research.. Also published at Brain Cancer Research & Understanding A Particular Hybrid.
Aucun commentaire:
Enregistrer un commentaire